Proteomics International is a medical technology company that specializes in proteomics, the study of proteins. The company has over 16 years of experience providing analytical services on a fee-for-service basis and has a strong research expertise in identifying new diagnostic protein biomarkers. Proteomics International has recently developed a predictive test for diabetic kidney disease called PromarkerD. This ground-breaking test is a promising advance in the field of personalized medicine.